Eribulin Treatment Promotes Re-Expression of Estrogen Receptor in Endocrine Therapy-Resistant Hormone Receptor-Positive Breast Cancer Cells

Scientists established hypoxia-resistant breast cancer cell lines by continuous culture in a hypoxic environment and investigated the effect of eribulin on hormone receptor-positive breast cancer cells that were resistant to endocrine blockade.